Breeze Acquisition Corp. II, a special purpose acquisition company, priced its $125 million initial public offering on May 12 to fund a future merger with a technology or healthcare-focused business. The offering gives the blank-check firm fresh capital to pursue a deal amid a more selective market for SPAC transactions.
The Irving, Texas-based company is offering 12.5 million units at $10.00 apiece, with units expected to begin trading on the Nasdaq Global Market on May 13 under the symbol "BREZU," the company said in a statement. Once the securities trade separately, the ordinary shares and rights will be listed under the symbols “BREZ” and “BREZR,” respectively.
The offering consists of one ordinary share and one right per unit. Each right allows the holder to receive one-fifth of an ordinary share when the company completes its initial business combination. The underwriters, co-led by IB Capital LLC and I-Bankers Securities, Inc., have a 45-day option to purchase up to an additional 1.875 million units to cover any over-allotments.
Breeze Acquisition Corp. II stated its strategy is to identify and merge with a business with global operations and "differentiated technology or capabilities." The company's search will focus on sectors such as healthcare, biotechnology, advanced manufacturing, robotics, and artificial intelligence. The net proceeds from the IPO are intended to be used to finance the business combination. The offering is expected to close on or about May 14, 2026.
This article is for informational purposes only and does not constitute investment advice.
